Le 29 décembre/December 2020

	Algernon Pharmaceuticals Inc. (sym: AGN) (the “Company” or “Algernon”)&nbsp;announced&nbsp;that the Company has elected to exercise its acceleration right under the warrant indenture (the “Indenture”) governing the common share purchase warrants of the Company (the “November Warrants”) issued on November 1, 2019, and trading under the symbol "AGN.WT" Pursuant to the terms of the Indenture, the Company may accelerate the expiry date of the November Warrants when the daily volume-weighted average trading price (the “VWAP”) of the common shares of the Company (the “Common Shares”) exceeds $0.35 for the preceding 20 consecutive trading days on the Canadian Securities Exchange (the “CSE”). As of the close of markets on December 11, 2020, the VWAP of the Common Shares on the CSE for 20 consecutive trading days has exceeded $0.35. Accordingly, the expiry date of the November Warrants is accelerated to January 21, 2021. The Company announces that as of today's date, there are approximately 6.5M November Warrants that have not yet been exercised.

	________________________

	 
	Algernon Pharmaceuticals Inc. (sym: AGN) (la Société&nbsp;ou Algernon) a annoncé que la Société avait choisi d'exercer son droit d'accélération en vertu de l'acte de souscription (l 'acte) régissant les bons de souscription d'actions ordinaires de la Société ( les «bons de souscription de novembre») émis le 1er novembre 2019 et négociés sous le symbole «AGN.WT» Conformément aux modalités de l'acte de fiducie, la société peut accélérer la date d'expiration des bons de souscription de novembre lorsque la négociation moyenne quotidienne pondérée en fonction du volume le prix (le VWAP) des actions ordinaires de la Société (les «actions ordinaires») dépasse 0,35 $ pour les 20 jours de bourse consécutifs précédents à la Bourse des valeurs canadiennes (le «CSE»). À la fermeture des marchés le 11 décembre 2020, le VWAP des actions ordinaires du CSE pendant 20 jours de bourse consécutifs a dépassé 0,35 $. Par conséquent, la date d'expiration des bons de souscription de novembre est reportée au 21 janvier 2021. La Société annonce qu'à la date d'aujourd'hui, environ 6,5 millions de bons de souscription de novembre n'ont pas encore été exercés.
<table border="1" cellpadding="1" cellspacing="1" >
<tbody>
<tr>
<td >
				Symbol/symbole:</td>
<td >
				AGN.WT</td>
</tr>
<tr>
<td >
				Exercise Price/Prix ​​de l'exercice:</td>
<td >
				$0.12/0 12$</td>
</tr>
<tr>
<td >
				New Expiry Date/Nouvelle date d'expiration:</td>
<td >
				January 21 2021/le janvier 21&nbsp;2021</td>
</tr>
<tr>
<td >
				Old Expiry Date/Ancienne date d'expiration:</td>
<td >
				May 1 2022/le mai&nbsp;1&nbsp;2022</td>
</tr>
</tbody>
</table>

	If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:listings@thecse.com" >Listings@thecse.com</a>

	Si&nbsp;vous&nbsp;avez&nbsp;des questions ou si&nbsp;vous&nbsp;avez&nbsp;besoin&nbsp;d'informations&nbsp;supplémentaires,&nbsp;veuillez&nbsp;contacter 
	le service des inscriptions au 416 367-7340 ou par&nbsp;courriel&nbsp;à&nbsp;l’adresse:&nbsp;&nbsp;<a href="mailto:listings@thecse.com" >listings@thecse.com</a>

Algernon Pharmaceuticals Inc. - Warrants

2020-1240 - Acceleration of Expiry Date – Algernon Pharmaceuticals Inc. - Warrants - AGN.WT

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.